Terms: = Liver cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717
270 results:
1. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
[TBL] [Abstract] [Full Text] [Related]
2. Secondary Polycythemia and Non-Islet Cell Tumor-induced Hypoglycemia in Advanced Hepatocellular Carcinoma: A Case Report.
Paramitha MS; Esa DF; Hustrini NM; Mulansari NA; Hasan I; Harahap AS
Acta Med Indones; 2024 Jan; 56(1):93-101. PubMed ID: 38561874
[TBL] [Abstract] [Full Text] [Related]
3. Extensive Hepatic Infarction due to Polycythemia Vera.
Furukawa K; Urano F; Okamura S; Kawashima H
J Gastrointestin Liver Dis; 2024 Mar; 33(1):18. PubMed ID: 38554424
[TBL] [Abstract] [Full Text] [Related]
4. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic jak2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
[TBL] [Abstract] [Full Text] [Related]
5. Natural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/jak2/STAT3 signal pathway.
Shi X; Lai Y; Liu W; Zhang X; Cang Y
Biochem Biophys Res Commun; 2024 Apr; 706():149758. PubMed ID: 38484571
[TBL] [Abstract] [Full Text] [Related]
6. Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity.
Zhang Y; Morris R; Brown GJ; Lorenzo AMD; Meng X; Kershaw NJ; Kiridena P; Burgio G; Gross S; Cappello JY; Shen Q; Wang H; Turnbull C; Lea-Henry T; Stanley M; Yu Z; Ballard FD; Chuah A; Lee JC; Hatch AM; Enders A; Masters SL; Headley AP; Trnka P; Mallon D; Fletcher JT; Walters GD; Šestan M; Jelušić M; Cook MC; Athanasopoulos V; Fulcher DA; Babon JJ; Vinuesa CG; Ellyard JI
J Exp Med; 2024 Apr; 221(4):. PubMed ID: 38417019
[TBL] [Abstract] [Full Text] [Related]
7. Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking jak2/STAT3 signaling.
Xie S; Li X; Yan J; Yu H; Chen S; Chen K
Immun Inflamm Dis; 2024 Feb; 12(2):e1146. PubMed ID: 38415977
[TBL] [Abstract] [Full Text] [Related]
8. TRIM29 modulates proteins involved in PTEN/AKT/mTOR and jak2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma.
Yin YT; Shi L; Wu C; Zhang MY; Li JX; Zhou YF; Wang SC; Wang HY; Mai SJ
Med Oncol; 2024 Feb; 41(3):79. PubMed ID: 38393440
[TBL] [Abstract] [Full Text] [Related]
9. Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma.
Yu H; Sun F; Xu Y; Yang H; Tian C; Li C; Kang Y; Hao L; Yang P
Hum Gene Ther; 2024 Mar; 35(5-6):177-191. PubMed ID: 38386514
[TBL] [Abstract] [Full Text] [Related]
10. Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of jak2/C21orf58/STAT3 Complex.
Jiang H; Wang Y; Wen D; Yu R; Esa SS; Lv K; Feng Q; Liu J; Li F; He L; Di X; Zhang S
Adv Sci (Weinh); 2024 Apr; 11(15):e2306623. PubMed ID: 38342622
[TBL] [Abstract] [Full Text] [Related]
11. Bacterial heat shock protein: A new crosstalk between T lymphocyte and macrophage via jak2/STAT1 pathway in bloodstream infection.
Yin S; Peng Y; Lin Y; Wu H; Wang B; Wang X; Chen W; Liu T; Peng H; Li X; Xu J; Wang M
Microbiol Res; 2024 May; 282():127626. PubMed ID: 38330817
[TBL] [Abstract] [Full Text] [Related]
12. The association between hepatic viral infections and cancers: a cross-sectional study in the Taiwan adult population.
Maliko M; Su FH; Kamiza AB; Su MJ; Yeh CC
Clin Exp Med; 2024 Jan; 24(1):20. PubMed ID: 38279980
[TBL] [Abstract] [Full Text] [Related]
13. Cepharanthine suppresses proliferation and metastasis and enhances apoptosis by regulating jak2/Stat3 pathway in hepatocellular carcinoma.
Liang Y; Li J; Xu H; Pang M; Hu C; Weng X; Xie W
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):94-100. PubMed ID: 38279472
[TBL] [Abstract] [Full Text] [Related]
14. Identification and validation of the association of Janus kinase 2 mutations with the response to immune checkpoint inhibitor therapy.
Chen P; Long J; Zhang J; Xie F; Wu W; Tian Z; Zhang S; Yu K
Inflamm Res; 2024 Feb; 73(2):263-276. PubMed ID: 38200372
[TBL] [Abstract] [Full Text] [Related]
15. SOCS2 inhibits hepatoblastoma metastasis via downregulation of the jak2/STAT5 signal pathway.
Lv Y; Xie X; Zou G; Kong M; Yang J; Chen J; Xiang B
Sci Rep; 2023 Dec; 13(1):21814. PubMed ID: 38071211
[TBL] [Abstract] [Full Text] [Related]
16. Astaxanthin Augmented the Anti-Hepatocellular Carcinoma Efficacy of Sorafenib Through the Inhibition of the jak2/STAT3 Signaling Pathway and Mitigation of Hypoxia within the Tumor Microenvironment.
Ren P; Tang Q; He X; Xu J; Wang Y; Xue C
Mol Nutr Food Res; 2024 Jan; 68(2):e2300569. PubMed ID: 38059808
[TBL] [Abstract] [Full Text] [Related]
17. Leonurine ameliorates the STAT3 pathway through the upregulation of SHP-1 to retard the growth of hepatocellular carcinoma cells.
Jung YY; Kim C; Shanmugam MK; Deivasigamani A; Chinnathambi A; Alharbi SA; Rangappa KS; Hui KM; Sethi G; Mohan CD; Ahn KS
Cell Signal; 2024 Feb; 114():111003. PubMed ID: 38048857
[TBL] [Abstract] [Full Text] [Related]
18. METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/jak2/STAT3 signaling pathway.
Hu J; Chen K; Hong F; Gao G; Dai X; Yin H
Cancer Gene Ther; 2024 Feb; 31(2):228-236. PubMed ID: 38030810
[TBL] [Abstract] [Full Text] [Related]
19. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents.
Waitman KB; de Almeida LC; Primi MC; Carlos JAEG; Ruiz C; Kronenberger T; Laufer S; Goettert MI; Poso A; Vassiliades SV; de Souza VAM; Toledo MFZJ; Hassimotto NMA; Cameron MD; Bannister TD; Costa-Lotufo LV; Machado-Neto JA; Tavares MT; Parise-Filho R
Eur J Med Chem; 2024 Jan; 263():115935. PubMed ID: 37989057
[TBL] [Abstract] [Full Text] [Related]
20. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression.
Wu R; Liu W; Yang Q; Zhang J; Hou P; Xiong J; Wu L; Li E
Sci Rep; 2023 Oct; 13(1):16998. PubMed ID: 37813900
[TBL] [Abstract] [Full Text] [Related]
[Next]
